Personalized medicine: Understanding probabilities and managing expectations

Journal of General Internal Medicine

Volumn 26, Issue 2, 2011, Pages 204-206

  Laksman, Zachary ^a   Detsky, Allan S ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

individualized medicine; managing expectations; personalized medicine; probabilities

Indexed keywords

DNA MICROARRAY; GENE THERAPY; HUMAN; MEDICAL PRACTICE; MOLECULAR MECHANICS; PERSONALIZED MEDICINE; REVIEW;

COMPREHENSION; DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; HUMANS; INDIVIDUALIZED MEDICINE; PROBABILITY;

EID: 78751584804     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1515-6     Document Type: Review

References (19)

1. TA Manolio FS Collins NJ Cox, et al. 2009 Finding the missing heritability of complex disease Nature 461 7265 747 53 1:CAS:528: DC%2BD1MXht1CisbrF 10.1038/nature08494 19812666
2. R Yung A Julius 2008 Epigenetics, aging, and autoimmunity Autoimmunity 41 4 329 35 1:CAS:528:DC%2BD1cXltFCmurY%3D 10.1080/08916930802024889 18432411 (Pubitemid 351593861)
3. Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune mediated diseases. Nature Reviews. Immunology. 2008;(8):631-43.
4. J Attia PA Ioannidis A Thakkinstian, et al. 2009 How to use an article about genetic association: C: what are the results and will they help me in caring for my patients? JAMA 301 3 304 08 1:CAS:528:DC%2BD1MXhtVart7s%3D 10.1001/jama.2008.993 19155457
5. TA Manolio 2010 Genomewide association studies and assessment of the risk of disease N Engl JMed 363 166 76 1:CAS:528:DC%2BC3cXptFWmt7w%3D 10.1056/NEJMra0905980
6. C Collins R Purohit H Podolsky, et al. 2006 The application of genomic and proteomic technologies in predictive, preventive and personalized medicine Vasc Pharmacol 45 258 67 1:CAS:528:DC%2BD28Xht1CqtbbP 10.1016/j.vph.2006.08.003 (Pubitemid 44765288)
7. JP Ioannidis 2010 Expectations, validity and reality in omics J Clin Epidemiol 63 9 945 49 10.1016/j.jclinepi.2010.04.002 20573481
8. LJ Lesko 2007 Personalized medicine: elusive dream or imminent reality? Clin Pharmacol Ther 81 6 807 16 1:STN:280:DC%2BD2s3psVaqug%3D%3D 10.1038/sj.clpt.6100204 17505496 (Pubitemid 46788303)
9. AM Holbrook JA Pereira R Labiris H McDonald JD Douketis M Crowther PS Wells 2005 Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 1095 106 1:CAS:528:DC%2BD2MXlsFaju78%3D 10.1001/archinte. 165.10.1095 15911722 (Pubitemid 40720733)
10. McWilliam A, Lutter R, Nardinelli C. "Health Care Savings from Personalizing Medicine Using Genetic Testing: The Case of Warfarin." 2006 AEI-Brookings Joint Center. Working paper 06-23. November 2006.
11. JL Anderson BD Horne SM Stevens, et al. 2007 Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation Circulation 116 2563 70 1:CAS:528:DC%2BD2sXhtlagsb3F 10.1161/CIRCULATIONAHA.107.737312 17989110 (Pubitemid 350179221)
12. TE Klein RB Altman N Eriksson, et al. 2009 Estimation of the warfarin dose with clinical and pharmacogenetic data N Engl J Med 360 8 753 64 10.1056/NEJMoa0809329 19228618
13. LM Meckley JM Gudgeon JL Anderson MS Williams DL Veenstra 2010 A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing Pharmcoeconomics 28 1 61 74 10.2165/11318240-000000000-00000
14. Paikin JS, Eikelboom JW, Cairns JA, Hirsch J. New antithrombotic agents-insights from clinical trials. Nature Reviews Cardiology. 2010,online.
15. M Allison 2008 Is personalized medicine finally arriving? Nat Biotechnol 26 5 509 17 1:CAS:528:DC%2BD1cXls12jtbw%3D 10.1038/nbt0508-509 18464779 (Pubitemid 351668034)
16. Z Su RM Gulick A Krambrink, et al. 2009 Response to vicriviroc in treatment experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of Aids clinic trials group A5211 J Infect Dis 200 11 1724 8 1:CAS:528:DC%2BD1MXhsFOlsrrP 10.1086/648090 19874179
17. EP Hoffman 2007 Skipping towards personalized medicine N Engl J Med 357 2719 22 1:CAS:528:DC%2BD1cXisVOntQ%3D%3D 10.1056/NEJMe0707795 18160693
18. AC Wu AL Fuhlbrigge 2008 Economic evaluation of pharmacogenetic tests Pharmacol Ther 84 2 272 4 1:STN:280:DC%2BD1cvps1Kiuw%3D%3D 10.1038/clpt.2008.127
19. MA Hamburg S Collins 2010 The Path to Personalized Medicine NEJM 363 301 4 1:CAS:528:DC%2BC3cXptFajt7Y%3D 10.1056/NEJMp1006304 20551152